TARS vs. APO
TARS (Tarsus Pharmaceuticals, Inc.) and APO (Apollo Global Management, Inc.) are both stocks. TARS operates in Biotechnology (Healthcare), while APO operates in Asset Management (Financial Services). Over the past 5 years, TARS returned 21.21%/yr vs 18.75%/yr for APO. Their 0.22 correlation means their historical movements had little consistent relationship.
Performance
TARS vs. APO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TARS achieves a -27.89% return, which is significantly lower than APO's -12.52% return.
TARS
- 1D
- -0.84%
- 1M
- -9.78%
- 6M
- -8.52%
- YTD
- -27.89%
- 1Y
- 44.67%
- 3Y*
- 47.84%
- 5Y*
- 21.21%
- 10Y*
- —
- ALL TIME*
- 25.04%
APO
- 1D
- 4.44%
- 1M
- 5.88%
- 6M
- -5.88%
- YTD
- -12.52%
- 1Y
- -7.73%
- 3Y*
- 17.12%
- 5Y*
- 18.75%
- 10Y*
- 27.17%
- ALL TIME*
- 20.44%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $435.36M | $496.01M | $510.65M | |
| $50.18M | $76.91M | $59.68M |
TARS vs. APO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceuticals, Inc. | -27.89% | 47.88% | 173.43% | 38.13% | -34.84% | -45.56% | 155.12% |
APO Apollo Global Management, Inc. | -12.52% | -11.12% | 79.87% | 49.44% | -9.59% | 53.25% | 15.09% |
Correlation
The correlation between TARS and APO is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.04 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.24 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2020 | 0.22 |
The correlation between TARS and APO shifts across timeframes, from 0.04 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TARS:
$2.54B
APO:
$72.40B
TARS:
-$1.13
APO:
$3.56
TARS:
4.72
APO:
2.55
TARS:
7.27
APO:
4.03
TARS:
$535.08M
APO:
$29.68B
TARS:
$483.93M
APO:
$26.52B
TARS:
-$39.55M
APO:
$9.28B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TARS vs. APO — Risk / Return Rank
TARS
APO
TARS vs. APO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Apollo Global Management, Inc. (APO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TARS | APO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.47 | ||
| Sortino ratioReturn per unit of downside risk | +2.10 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 0.97 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | -0.36 | +2.00 |
| Martin ratioReturn relative to average drawdown | 3.16 | -0.76 | +3.93 |
Loading charts...
Drawdowns
TARS vs. APO - Drawdown Comparison
The maximum TARS drawdown since its inception was -77.67%, which is greater than APO's maximum drawdown of -56.99%. Use the drawdown chart below to compare losses from any high point for TARS and APO.
Loading charts...
Drawdown Indicators
| TARS | APO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.67% | -56.99% | -20.68% |
Max Drawdown (1Y)Largest decline over 1 year | -32.00% | -34.05% | +2.05% |
Max Drawdown (3Y)Largest decline over 3 years | -45.08% | -42.82% | -2.26% |
Max Drawdown (5Y)Largest decline over 5 years | -62.67% | -42.82% | -19.85% |
Max Drawdown (10Y)Largest decline over 10 years | — | -53.48% | — |
Current DrawdownCurrent decline from peak | -28.45% | -28.10% | -0.35% |
Average DrawdownAverage peak-to-trough decline | -40.18% | -16.50% | -23.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.51% | 16.05% | +0.46% |
Volatility
TARS vs. APO - Volatility Comparison
Tarsus Pharmaceuticals, Inc. (TARS) has a higher volatility of 18.88% compared to Apollo Global Management, Inc. (APO) at 9.03%. This indicates that TARS's price experiences larger fluctuations and is considered to be riskier than APO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TARS | APO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.88% | 9.03% | +9.85% |
Volatility (6M)Calculated over the trailing 6-month period | 33.36% | 28.28% | +5.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.36% | 36.03% | +10.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.69% | 37.31% | +21.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.62% | 37.93% | +26.69% |
Dividends
TARS vs. APO - Dividend Comparison
TARS has not paid dividends to shareholders, while APO's dividend yield for the trailing twelve months is around 1.67%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
APO Apollo Global Management, Inc. | 1.67% | 1.38% | 1.10% | 1.81% | 2.51% | 2.90% | 4.72% | 4.23% | 7.86% | 5.53% | 6.46% | 12.91% |
TARS Tarsus Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TARS vs. APO - Financials Comparison
This section allows you to compare key financial metrics between Tarsus Pharmaceuticals, Inc. and Apollo Global Management, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TARS vs. APO - Profitability Comparison
TARS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Tarsus Pharmaceuticals, Inc. reported a gross profit of 152.66M and revenue of 162.05M. Therefore, the gross margin over that period was 94.2%.
APO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Apollo Global Management, Inc. reported a gross profit of 4.93B and revenue of 4.93B. Therefore, the gross margin over that period was 100.0%.
TARS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Tarsus Pharmaceuticals, Inc. reported an operating income of -6.12M and revenue of 162.05M, resulting in an operating margin of -3.8%.
APO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Apollo Global Management, Inc. reported an operating income of 330.00M and revenue of 4.93B, resulting in an operating margin of 6.7%.
TARS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Tarsus Pharmaceuticals, Inc. reported a net income of -6.97M and revenue of 162.05M, resulting in a net margin of -4.3%.
APO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Apollo Global Management, Inc. reported a net income of -1.91B and revenue of 4.93B, resulting in a net margin of -38.7%.
Frequently Asked Questions
TARS and APO have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TARS has higher volatility (18.88%) compared to APO (9.03%). In terms of maximum drawdown, TARS dropped -77.67% vs APO's -56.99%.
TARS currently has the higher Sharpe Ratio (1.13 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TARS and APO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer